Palmetto
Palmetto Finalizes Medicare Coverage for MRD Cancer Testing
To receive coverage, the patient must have a personal history of cancer where the type and staging are within the intended use of the test.
Genomic Testing Cooperative's Hematologic Neoplasms, Solid Tumor Tests Receive NY State Approval, Medicare Coverage
The next-generation sequencing-based tests can be performed on small samples, including needle aspiration samples, and use artificial intelligence software.
Veracyte Bladder Cancer Test Receives Medicare Coverage
The patient must be a candidate for multiple potential treatments with varying levels of intensity or multiple therapies.
Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests
Under the local coverage determination, tests to help identify patients who may benefit from a prostate biopsy would be covered under certain conditions.
Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection
Under the policy, covered tests must provide information about active rejection status or cellular or antibody-mediated rejection status.